ABUS vs MSI · P/E 5.4, rev $6.2M vs P/E 33, rev $11.68B
Arbutus Biopharma Corp (ABUS) versus Motorola Solutions Inc (MSI) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Motorola Solutions Inc (MSI) is a communication equipment company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported MSI revenue for 2025-12-31 was $11.68B. Net income was $2.15B. Revenue was up 8.0% from 2024-12-31 to 2025-12-31. MSI currently screens at market cap $68.32B and trailing P/E 33.2.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. MSI currently screens at market cap $68.32B and trailing P/E 33.2.
Not investment advice. Open the ABUS and MSI stock pages for the full models.
Not investment advice.